Federal contract award
W81XWH20C0066
COVID-19 DHA 2018.1 SBIR PHASE III MEDICAL R&D CONTRACT PROPOSAL TITLED: "TARGETING SPLA2 FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) ASSOCIATED WITH SARS-COV-2" LOG #19000053
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN94 — OTHER MEDICAL - ENGINEERING DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $9.9M |
| Current contract value | $10.6M |
| Potential contract value / ceiling | $10.6M |
| Start date | Jun 19, 2020 |
| Current end date | Sep 29, 2023 |
| Potential end date | Sep 29, 2023 |
| Latest award activity | Sep 5, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 5, 2025 | P00007 | $-645.0K | TARGETING SPLA2 FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME ASSOCIATED WITH SARS-COV-2 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.